Physician

Navid David Malakouti, M.D.

According to 2025 Medicare claims, Navid Malakouti, M.D. (NPI: 1437578051) practices dermatology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is SILVER FALLS DERMATOLOGY, LLC (NPI: 1134375421; TIN: 262636087) and primary practice location at 98012-1797.

Malakouti's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 332 traditional Medicare patients, billed 6,103 HCPCS/CPT codes, and received $174,864 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 520 prescription claims across 258 beneficiaries totaling $159,926 in drug costs, led by Tacrolimus (Tacrolimus). Open Payments data shows 89 records totaling $5,258. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $50,137 to $174,864. Similarly, Part D prescription costs have risen steadily, from $4,187 to $159,926. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$87K$175K2019 Medicare payment: $50,137 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $72,316 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $94,950 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $95,197 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $85,971 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $174,864 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
20192471,239$50,137
20203623,653$72,316
20213404,058$94,950
20223743,381$95,197
20233943,548$85,971
20243326,103$174,864

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$83K$166K2015 Drug cost: $4,187 (USD; Tot_Drug_Cst)2016 Drug cost: $2,279 (USD; Tot_Drug_Cst)2017 Drug cost: $4,536 (USD; Tot_Drug_Cst)2018 Drug cost: $6,494 (USD; Tot_Drug_Cst)2019 Drug cost: $15,420 (USD; Tot_Drug_Cst)2020 Drug cost: $99,368 (USD; Tot_Drug_Cst)2021 Drug cost: $49,386 (USD; Tot_Drug_Cst)2022 Drug cost: $166,341 (USD; Tot_Drug_Cst)2023 Drug cost: $122,072 (USD; Tot_Drug_Cst)2024 Drug cost: $159,926 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151232$4,187
2016N/R18$2,279
20172362$4,536
20181943$6,494
2019122195$15,420
2020191432$99,368
2021219460$49,386
2022253586$166,341
2023246542$122,072
2024258520$159,926

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths7284$78
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more181257$63
11102Biopsy of related skin growth, first growth6973$60
17000Destruction of precancer skin growth, 1 growth116136$36
17003Destruction of precancer skin growth, 2-14 growths74370$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
TacrolimusTacrolimus24705$3,386
Clobetasol PropionateClobetasol Propionate842,416$3,266
KetoconazoleKetoconazole632,097$1,048
Triamcinolone AcetonideTriamcinolone Acetonide812,663$973
MetronidazoleMetronidazole19590$973

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.89$5,258GENZYME CORPORATION
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Navid David Malakouti, M.D.?

Tedicare shows public-source Medicare data for Navid David Malakouti, M.D. (NPI 1437578051), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Navid David Malakouti, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Navid David Malakouti, M.D.?

Navid David Malakouti, M.D. is linked to SILVER FALLS DERMATOLOGY, LLC (billing NPI 1134375421) in the available physician profile data.

Does Navid David Malakouti, M.D. have Open Payments data?

Navid David Malakouti, M.D. has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.